• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳水化合物抗原19-9作为食管癌肿瘤标志物的作用。

The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer.

作者信息

McKnight A, Mannell A, Shperling I

机构信息

Department of Nuclear Medicine, Witwatersrand University Medical School, Johannesburg, South Africa.

出版信息

Br J Cancer. 1989 Aug;60(2):249-51. doi: 10.1038/bjc.1989.263.

DOI:10.1038/bjc.1989.263
PMID:2765375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2247033/
Abstract

Carcinoma of the oesophagus is endemic in certain well demarcated areas throughout the world, and a method of screening population groups at high risk for oesophageal cancer is urgently needed. In this study the sensitivity and specificity of the carbohydrate antigen CA19-9 as a marker of carcinoma of the oesophagus in African patients was examined. The normal range was established by assay of serum samples from healthy black blood donors, using a solid phase radioimmunoassay with mouse monoclonal antibody to CA19-9 labelled with 125I. Serum concentrations of CA19-9 were then measured in 100 African patients with oesophageal cancer and 28 patients with benign oesophageal disease. The upper limit of CA19-9 in the normal controls was 40 U ml-1. Thirty-four patients with oesophageal cancer and five with benign oesophageal disease had elevated levels. Therefore, in this series, the sensitivity of CA19-9 as a marker of oesophageal cancer was 34% and the specificity was 82%. While CA19-9 is not sufficiently sensitive to be used as a screening test of oesophageal cancer, it compares favourably with other known tumour markers of this disease, and may have a role in monitoring disease recurrence and response to treatment.

摘要

食管癌在世界上某些界限分明的地区呈地方性流行,因此迫切需要一种对食管癌高危人群进行筛查的方法。在本研究中,对糖类抗原CA19 - 9作为非洲患者食管癌标志物的敏感性和特异性进行了检测。通过使用用125I标记的抗CA19 - 9小鼠单克隆抗体的固相放射免疫分析法,对健康黑人献血者的血清样本进行检测,从而确定正常范围。然后对100例非洲食管癌患者和28例食管良性疾病患者的血清CA19 - 9浓度进行了测量。正常对照组中CA19 - 9的上限为40 U/ml。34例食管癌患者和5例食管良性疾病患者的CA19 - 9水平升高。因此,在该系列研究中,CA19 - 9作为食管癌标志物的敏感性为34%,特异性为82%。虽然CA19 - 9作为食管癌筛查试验的敏感性不够高,但与该疾病的其他已知肿瘤标志物相比具有优势,并且可能在监测疾病复发和治疗反应方面发挥作用。

相似文献

1
The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer.碳水化合物抗原19-9作为食管癌肿瘤标志物的作用。
Br J Cancer. 1989 Aug;60(2):249-51. doi: 10.1038/bjc.1989.263.
2
Clinical importance of tumour markers in the diagnosis of squamous-cell carcinoma of the esophagus.
Panminerva Med. 1990 Jul-Sep;32(3):105-7.
3
Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer.将酶联肽核酸凝集素结合试验与CA19-9和癌胚抗原放射免疫测定法相比较,作为胰腺癌的诊断性血液检测方法。
Br J Cancer. 1989 Jun;59(6):949-53. doi: 10.1038/bjc.1989.202.
4
Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.胃肠道癌患者中TAG-72、CA19-9和CEA血清检测的比较。
Jpn J Clin Oncol. 1989 Sep;19(3):242-8.
5
Failure of CA19-9 to detect asymptomatic colorectal carcinoma.CA19-9检测无症状结直肠癌的失败情况。
Br J Cancer. 1991 Jun;63(6):975-6. doi: 10.1038/bjc.1991.213.
6
Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.食管癌患者血清中胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子结合蛋白-III(IGFBP-III)水平及其与癌胚抗原和糖类抗原19-9的关系。
Int J Clin Pract. 2006 Dec;60(12):1604-8. doi: 10.1111/j.1742-1241.2006.00854.x. Epub 2006 May 16.
7
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fraction.食管鳞状细胞癌中的肿瘤标志物:细胞溶质和膜部分的免疫测定法
Int J Biol Markers. 1990 Jan-Mar;5(1):7-13.
8
[Usefulness of tumor markers in the diagnosis of squamous carcinoma of the esophagus].
Minerva Chir. 1988 Sep 30;43(18):1469-71.
9
[Carbohydrate antigens in pleural effusion from patients with lung cancer].[肺癌患者胸腔积液中的碳水化合物抗原]
Nihon Kyobu Shikkan Gakkai Zasshi. 1989 Jun;27(6):673-8.
10
Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients.血清 CXCL-8 与经典肿瘤标志物在食管癌(OC)患者中的临床意义比较。
Clin Exp Med. 2019 May;19(2):191-199. doi: 10.1007/s10238-019-00548-9. Epub 2019 Feb 28.

引用本文的文献

1
Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.血浆CYFRA21-1和NSE水平在食管鳞状细胞癌患者中的诊断、预后及复发监测价值
Front Oncol. 2022 Jan 21;11:789312. doi: 10.3389/fonc.2021.789312. eCollection 2021.
2
Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma.鉴定食管鳞癌中新型 SEREX 抗原家族 ECSA。
Proteome Sci. 2011 Jun 23;9(1):31. doi: 10.1186/1477-5956-9-31.
3
Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma.食管鳞状细胞癌患者血清中含三联基序蛋白21抗体的存在情况。
Cancer Sci. 2006 May;97(5):380-6. doi: 10.1111/j.1349-7006.2006.00192.x.
4
Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.食管癌患者血清癌胚抗原、糖类抗原19-9及鳞状细胞癌抗原水平的临床意义
World J Surg. 2004 Jul;28(7):680-5. doi: 10.1007/s00268-004-6865-y. Epub 2004 Jun 4.

本文引用的文献

1
[Incidence of esophageal cancer in Côte-d'Or (France) (author's transl)].
Gastroenterol Clin Biol. 1981 Mar;5(3):251-6.
2
Research on esophageal cancer in China: a review.中国食管癌研究综述。
Cancer Res. 1980 Aug;40(8 Pt 1):2633-44.
3
Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.利用美国国立癌症研究所血清库对CA 19-9免疫放射分析进行的初步临床评估。
Int J Cancer. 1984 Mar 15;33(3):339-45. doi: 10.1002/ijc.2910330310.
4
Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.晚期生殖细胞肿瘤血清肿瘤标志物与化疗及手术反应的相关性
Cancer. 1984 Mar 15;53(6):1440-5. doi: 10.1002/1097-0142(19840315)53:6<1440::aid-cncr2820530637>3.0.co;2-g.
5
Specific antigen in serum of patients with colon carcinoma.结肠癌患者血清中的特异性抗原。
Science. 1981 Apr 3;212(4490):53-5. doi: 10.1126/science.6163212.
6
Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).通过循环癌胚抗原(C.E.A.)放射免疫测定法检测大肠癌复发
Lancet. 1974 Sep 7;2(7880):535-40. doi: 10.1016/s0140-6736(74)91872-8.
7
Cancer of the oesophagus in Soweto.索韦托地区的食管癌
S Afr Med J. 1985 May 25;67(21):839-42.
8
The clinical usefulness and limitations of tumor markers.肿瘤标志物的临床应用价值与局限性。
Surg Gynecol Obstet. 1988 Jun;166(6):567-79.
9
Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.碳水化合物抗原19-9作为肝细胞癌的血清标志物:与甲胎蛋白的比较。
Br J Cancer. 1987 Jul;56(1):86-8. doi: 10.1038/bjc.1987.160.
10
Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
Gastroenterology. 1986 Feb;90(2):343-9. doi: 10.1016/0016-5085(86)90930-3.